These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 35681419)

  • 1. Across Dimensions: Developing 2D and 3D Human iPSC-Based Models of Fragile X Syndrome.
    Lee A; Xu J; Wen Z; Jin P
    Cells; 2022 May; 11(11):. PubMed ID: 35681419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons.
    Graef JD; Wu H; Ng C; Sun C; Villegas V; Qadir D; Jesseman K; Warren ST; Jaenisch R; Cacace A; Wallace O
    Eur J Neurosci; 2020 May; 51(10):2143-2157. PubMed ID: 31880363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feasibility and utility of hair follicle sampling to measure FMRP and FMR1 mRNA in children with or without fragile X syndrome: a pilot study.
    Jalnapurkar I; Frazier JA; Roth M; Cochran DM; Foley A; Merk T; Venuti L; Ronco L; Raines S; Cadavid D
    J Neurodev Disord; 2022 Dec; 14(1):57. PubMed ID: 36494616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation Delay of Human GABAergic Neurogenesis in Fragile X Syndrome Pluripotent Stem Cells.
    Zhang A; Sokolova I; Domissy A; Davis J; Rao L; Hana Utami K; Wang Y; Hagerman RJ; Pouladi MA; Sanna P; Boland MJ; Loring JF
    Stem Cells Transl Med; 2022 Jun; 11(6):613-629. PubMed ID: 35556144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
    Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
    Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.
    Brighi C; Salaris F; Soloperto A; Cordella F; Ghirga S; de Turris V; Rosito M; Porceddu PF; D'Antoni C; Reggiani A; Rosa A; Di Angelantonio S
    Cell Death Dis; 2021 May; 12(5):498. PubMed ID: 33993189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic variability to medication management: an update on fragile X syndrome.
    Elhawary NA; AlJahdali IA; Abumansour IS; Azher ZA; Falemban AH; Madani WM; Alosaimi W; Alghamdi G; Sindi IA
    Hum Genomics; 2023 Jul; 17(1):60. PubMed ID: 37420260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unstable mutations in the FMR1 gene and the phenotypes.
    Loesch D; Hagerman R
    Adv Exp Med Biol; 2012; 769():78-114. PubMed ID: 23560306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pluripotent stem cell models of Fragile X syndrome.
    Bhattacharyya A; Zhao X
    Mol Cell Neurosci; 2016 Jun; 73():43-51. PubMed ID: 26640241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.
    Ludwig AL; Espinal GM; Pretto DI; Jamal AL; Arque G; Tassone F; Berman RF; Hagerman PJ
    Hum Mol Genet; 2014 Jun; 23(12):3228-38. PubMed ID: 24463622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
    Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
    PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Trajković J; Makevic V; Pesic M; Pavković-Lučić S; Milojevic S; Cvjetkovic S; Hagerman R; Budimirovic DB; Protic D
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
    Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
    Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation.
    Lu P; Chen X; Feng Y; Zeng Q; Jiang C; Zhu X; Fan G; Xue Z
    Sci China Life Sci; 2016 Nov; 59(11):1093-1105. PubMed ID: 27730449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling.
    Gerhardt J
    Brain Res; 2017 Feb; 1656():55-62. PubMed ID: 26475977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
    J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades.
    Gao MM; Shi H; Yan HJ; Long YS
    J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.